Abstract
dc:descriptionα-synuclein (ASYN) is a neuronal protein implicated in Parkinson’s disease (PD) pathogenesis. Duplications/triplications or point mutations (A53T, A30P, E46K) in the gene encoding for ASYN lead to PD. However, the pathogenic effects of ASYN, and in particular of its mutant forms, are unknown. Such effects may be closely linked to ASYN degradation and its effects on intracellular protein degradation pathways. Previous studies, based on isolated liver lysosomes, have shown that wild type (WT) ASYN can be degraded by Chaperone Mediated Autophagy (CMA). In this selective degradation pathway, WT ASYN binds through its KEFQR motif to the receptor Lamp2a and is internalized and degraded within lysosomes. Moreover, it has been shown in the same in vitro lysosome system that mutant ASYNs block CMA by binding to Lamp2a without being internalized.In this study, we wished to examine in a neuronal cell context whether 1) WT ASYN can de degraded via CMA, 2) CMA dysfunction caused by mutant forms of ASYN is responsible for the impairment of lysosomal degradation, and 3) toxicity attributed to mutant ASYNs is due, in part, to the impairment of lysosomal function. To address the first question we generated stably tranfected inducible neuronal cell lines (human SH-SY5Y, rat PC12), expressing WT ASYN and the mutant ΔDQ/WT ASYN that lacks the CMA recognition motif. In these lines we compared the rate of degradation and half life of both forms. We, alternatively, assessed the effect of the downregulation of Lamp2a on the levels of WT ASYN. We concluded that WT ASYN can be degraded through CMA in both cell lines. To address the second/third question we generated stably tranfected inducible neuronal cell lines (human SH-SY5Y, rat PC12), expressing A53T ASYN and the mutant ΔDQ/A53T ASYN that lacks the CMA recognition motif. In these lines, we employed a pulse-chase assay to measure lysosomal function, and observed a significant decrease in total lysosomal degradation induced by A53T ASYN in large part due to CMA impairment. Nevertheless, no significant toxicity was detected. However, in neuronally differentiated SH-SH5Y cells both WT and A53T ASYN were associated with gradual toxicity, attenuated in the case of WT/ΔDQ. Pharmacological inhibition of dopamine synthesis lead to improvement of lysosomal function and cell survival, indicating that dopamine-modified ASYN can trigger lysosomal dysfunction due to CMA impairment, which can ultimately lead to increased to cell death. Therefore lysosomal degradation may be the target for therapeutic interventions in PD.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vogiatzi, Tereza-Andriani
- Βογιατζή, Τερέζα - Ανδριανή
Subjects
dc:subject × 22- Α-συνουκλεΐνη
- Νόσος Parkinson
- Νευροεκφυλιστικές νόσοι
- Μακροαυτοφαγία
- Αυτοφαγία διαμεσολαβούμενη από τσαπερόνες
- Λυσοσωμική αποικοδόμηση πρωτεϊνών
- Μόνιμα διαμολυσμένες επαγόμενες νευρωνικές κυτταρικές σειρές
- Λυσοσωμική δυσλειτουργία
- Ντοπαμίνη
- A - synuclein
- Parkinson's disease
- Neurodegenerative disorders
- Macroautophagy
- Chaperone mediated autophagy (CMA)
- Lysosmal degradation
- Stably tranfected inducbile neuronal cell lines
- Lysosmal dysfunction
- Dopamine
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27873